ChemAnalyst Data Pvt Ltd

North America The North American  Potassium Clavulanate  market experienced significant price volatility in Q4 2024, beginning with sharp increases in October, followed by fluctuating dynamics through year-end. Prices surged in October, driven by rising Asian import costs and severe port congestion. November extended this trend as mounting production costs in China and dollar-yuan fluctuations applied further pressure. Anticipation of Trump’s proposed 50% tariff on Chinese imports spurred accelerated procurement, intensifying demand. Despite partial stabilization of port operations after the ILA strike, persistent delays at major ports kept freight rates elevated. By December, supply-demand dynamics stabilized, with steady procurement from pharmaceutical manufacturers. However, the quarter closed on a challenging note, as output recorded its steepest decline in 18 months due to weakening new orders. Supply chain disruptions remained a critical concern, particularly at East and...